NTNX 10-Q Quarterly Report Jan. 31, 2020 | Alphaminr

Effective Date August 11, 2021

These terms and conditions govern your use of the website alphaminr.com and its related services.

These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.

Subscription

Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.

Fees

We will provide you with advance notice of any change in fees.

Usage

You represent that you are of legal age to form a binding contract. You are responsible for any activity associated with your account. The account can be logged in at only one computer at a time.
The Services are intended for your own individual use. You shall only use the Services in a manner that complies with all laws. You may not use any automated software, spider or system to scrape data from Alphaminr.

Limitation of Liability

Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.

TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.

If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.

NUTANIX, INC.

10-Ks and 10-Qs

10-Q	Quarter ended Oct. 31, 2024
10-K	Fiscal year ended July 31, 2024
10-Q	Quarter ended April 30, 2024
10-Q	Quarter ended Jan. 31, 2024
10-Q	Quarter ended Oct. 31, 2023
10-K	Fiscal year ended July 31, 2023
10-Q	Quarter ended April 30, 2023
10-Q	Quarter ended Jan. 31, 2023
10-Q	Quarter ended Oct. 31, 2022
10-K	Fiscal year ended July 31, 2022
10-Q	Quarter ended April 30, 2022
10-Q	Quarter ended Jan. 31, 2022
10-Q	Quarter ended Oct. 31, 2021
10-K	Fiscal year ended July 31, 2021
10-Q	Quarter ended April 30, 2021
10-Q	Quarter ended Jan. 31, 2021
10-Q	Quarter ended Oct. 31, 2020
10-K	Fiscal year ended July 31, 2020
10-Q	Quarter ended April 30, 2020
10-Q	Quarter ended Jan. 31, 2020
10-Q	Quarter ended Oct. 31, 2019
10-K	Fiscal year ended July 31, 2019
10-Q	Quarter ended April 30, 2019
10-Q	Quarter ended Jan. 31, 2019
10-Q	Quarter ended Oct. 31, 2018
10-K	Fiscal year ended July 31, 2018
10-Q	Quarter ended April 30, 2018
10-Q	Quarter ended Jan. 31, 2018
10-Q	Quarter ended Oct. 31, 2017
10-K	Fiscal year ended July 31, 2017
10-Q	Quarter ended April 30, 2017
10-Q	Quarter ended Jan. 31, 2017
10-Q	Quarter ended Oct. 31, 2016

PROXIES

DEF 14A	Filed on Oct. 22, 2024
DEF 14A	Filed on Oct. 23, 2023
DEF 14A	Filed on Oct. 24, 2022
DEF 14A	Filed on Oct. 26, 2021
DEF 14A	Filed on Oct. 26, 2020
DEF 14A	Filed on Oct. 30, 2019
DEF 14A	Filed on Nov. 5, 2018
DEF 14A	Filed on Nov. 3, 2017

TABLE OF CONTENTS

Part I. Financial Information Item 1. Financial Statements (unaudited)Note 1. Overview and Basis Of Presentation Note 2. Revenue, Deferred Revenue and Deferred Commissions Note 3. Fair Value Measurements Note 4. Balance Sheet Components Note 5. Convertible Senior Notes Note 6. Leases Note 7. Commitments and Contingencies Note 8. Stockholders Equity Note 9. Equity Incentive Plans Note 10. Income Taxes Note 11. Net Loss Per Share Note 12. Segment Information Item 2. Management S Discussion and Analysis Of Financial Condition and Results Of Operations Item 3. Quantitative and Qualitative Disclosures About Market Risk Item 4. Controls and Procedures Part II. Other Information Item 1. Legal Proceedings Item 1A. Risk Factors Item 2. Unregistered Sales Of Equity Securities and Use Of Proceeds Item 3. Defaults Upon Senior Securities Item 4. Mine Safety Disclosures Item 5. Other Information Item 6. Exhibits

Exhibits

10.1+ Amended and Restated 2016 Employee Stock Purchase Plan and forms of equity agreements thereunder 10.2+ Offer Letter, dated as of October 29, 2019, by and between the Registrant and Tarkan Maner 31.1 Certification of Principal Executive Officer pursuant to Section302 of the Sarbanes-Oxley Act of 2002 31.2 Certification of Principal Financial Officer pursuant to Section302 of the Sarbanes-Oxley Act of 2002 32.1* Certification of Chief Executive Officer pursuant to 18 U.S.C. Section1350, as adopted pursuant to Section906 of the Sarbanes-Oxley Act of 2002 32.2* Certification of Chief Financial Officer pursuant to 18 U.S.C. Section1350, as adopted pursuant to Section906 of the Sarbanes-Oxley Act of 2002

* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.

FUND	NUMBER OF SHARES	VALUE ($)	PUT OR CALL

DIRECTORS	AGE	BIO	OTHER DIRECTOR MEMBERSHIPS

Customers

Customer name	Ticker
Fiserv, Inc.	FISV

No Suppliers Found

Owner	Position	Direct Shares	Indirect Shares